Torrent Pharmaceuticals Limited CC-Feb26.pdf · 2026-02-13
Thank you. So, quick question. Once the JB merger happens, right, what would be the margin guidance, if at all, considering you are going to have cost savings, JB currently have an EBITDA margin of 18% to 19%. You are sitting at 32%. Even if we consider the synergies, is this going to be margin accretive for our businesses? I understand that you have not done on the revenue side so far, but you must have some ballpark numbers in your head.
Okay. Thanks for that. So, how is U.S. looking for you? I know there was no tariff on Pharma in any case, right? But after this tariff news out of the way, are you seeing the potential to grow above 20% on the U.S. side in the subsequent quarters?